|
(11) | EP 1 732 599 A1 |
| (12) |
|
|
|
|
||||||||||||||||||||
| (54) | USE OF EMMPRIN ANTAGONISTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH EXCESSIVE ANGIOGENESIS |